Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07227259

Health Properties of Pecan Nut Consumption

Assessment of Systematic Health Properties of Pecan Nut Consumption: Gut, Vascular, Metabolic and Cognitive Outcomes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

The main goal of this clinical study is to see if consuming pecan nuts will result in improvements in overall body metabolism such as in blood lipids, markers of inflammation, blood pressure, cognitive performance and changes in bacteria living in the gut in adults 45 to 75 years of age. Participants will take part in two 3-month intervention periods, separated by 4-6 weeks, in random order ( a total of approximately 7 months). During one intervention period, they will include pecan nuts in their diet each day, while during the other intervention period they will avoid pecans in their diet. There will be an initial screening visit to evaluate eligibility and four study visits to the clinic. Participants will be asked to complete some questionnaires about their diet, physical and cognitive health, and provide blood and stool samples, and have their blood pressure measured.

Conditions

Interventions

TypeNameDescription
OTHERpecan nutDose - 2 ounces of pecan nuts, daily

Timeline

Start date
2025-11-15
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2025-11-12
Last updated
2026-02-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07227259. Inclusion in this directory is not an endorsement.

Health Properties of Pecan Nut Consumption (NCT07227259) · Clinical Trials Directory